Digital lifestyle platform after rehabilitation to support self-management
Official title: Feasibility Study of a Digital Interactive Life-style Platform for Individuals After Rehabilitation
Run by Insel Gruppe AG, University Hospital Bern · NCT07597031 · Data updated 2026-11-12
A digital, patient-facing platform is being tested to see if people who recently finished inpatient rehabilitation will use it and benefit from personalized lifestyle guidance at home.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 2 sites (Bern, Canton of Bern and 1 other locations) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT07597031 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) who are within 10 days of discharge from inpatient rehabilitation and have ACS, COPD, fragility fracture, or minor stroke, with internet-enabled device access and ability to consent.
✕Probably not a fit
Individuals without access to suitable devices, significant cognitive or language barriers, or inability to use digital health tools may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a feasibility study of a digital lifestyle platform designed for adults after discharge from inpatient rehabilitation for COPD, acute coronary syndrome, fragility fracture, or minor stroke. The study will assess usability, engagement, and adherence to self-management and healthy behaviors in an outpatient setting. It compares the digital platform plus usual care to usual care alone, with content tailored to individual needs and updated based on user feedback. Telemedicine features include educational content, lifestyle suggestions, and professional input to support long-term health. The project emphasizes real-world applicability and potential to reduce relapse and healthcare use after rehabilitation.
Why it matters
Potential benefit: If successful, patients may experience better engagement with post-rehab care and improved long-term self-management of their condition.
How similar studies have gone: Previous telemedicine and digital rehab approaches have shown promise for improving engagement and self-management, though this exact platform and population are being tested for feasibility.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years) * 10 or less days before discharge from inpatient rehabilitation at the Bern Rehab Center in Heiligenschwendi or the Insel Hospital (both belonging to the Insel Group) * Belonging to one of the following clinical cohorts: acute coronary syndrome or ischemic heart failure; chronic obstructive pulmonary disease (COPD) - clinically diagnosed and confirmed by pulmonary specialist; fragility fracture - e.g., hip fracture or other low-energy fractures; minor stroke, clinically confirmed ischemic or hemorrhagic stroke with mild neurological deficits. * Able to provide informed consent. * Access to and ability to use a device that has internet access (e.g., tablet, smartphone, laptop, etc.). Exclusion Criteria: * Cognitive or psychiatric condition interfering with consent or use of the app. * Physical disability preventing digital device use without support. * Heavy language production or comprehension impairments.
Where it's running
-
University Hospital Inselspital
Bern, Canton of Bern, Switzerland Recruiting -
Center for Rehabilitation & Sports Medicine, Berner Reha Zentrum
Schwendi, Heiligenschwendi, Switzerland Recruiting
Study contacts
- Principal investigator: Matthias Wilhelm, Prof. Dr. med. — Center for Rehabilitation & Sports Medicine, Berner Reha Zentrum and Inselspital, Bern University Hospital, University of Bern
- Study coordinator: Matthias Wilhelm, Prof. Dr. med.
- Email: matthias.wilhelm@insel.ch
- Phone: +41 632 89 86
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
-
Targeted NMES to improve breathing and leg/extra muscle strength in COPD
This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
PBMT with a pulmonary rehab program for COPD patients
A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.
-
Common femoral vein-to-artery diameter ratio to detect elevated LVEDP
Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.